samedan logo
 
 
spacer
home > ict > autumn 2017 > handle with care
PUBLICATIONS
International Clinical Trials

Handle with Care

Catizone states, “When you are in the business of creating lifesaving drugs, the mundane detail of shipping logistics is not usually the first concern that springs to mind.

“The biopharmaceutical industry, by its very nature, is one in which underlying business operations are often perceived as secondary to the higher calling of treating or even curing some of the most devastating diseases on earth. But ensuring that clinical samples reach their destination safely, securely, and at the right temperature is just as crucial as any element of the drug discovery process (1).”

Medical laboratory and clinical personnel have always needed to transport biological samples from the patient source, between clinics and laboratories for centralised testing in clinical trials. However, a growing number of trial projects are now being performed on a global scale, with activity significantly increasing in developing countries, particularly Asian and Latin American locations (2).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sue Fletcher is a BSc Hons graduate with a number of years’ experience working in research labs. Having attained the necessary standard on a Civil Aviation Authority-Approved course, Sue is certified in the Carriage of Diagnostic and Infectious Substances by Air and provides advice and training seminars across the country on UN3373 Dangerous Goods Packaging.
spacer
Sue Fletcher
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure

WILMINGTON, Mass.--(BUSINESS WIRE)--Feb. 1, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced a new agreement which grants Charles River commercial access to AstraZeneca’s (NYSE: AZN) high-throughput screening (HTS) and compound management infrastructure. Through the agreement, Charles River will perform HTS programs for its clients utilizing AstraZeneca’s state-of-the-art HTS facility.
More info >>

White Papers

Crunch Time: The Impact of Serialisation Requirements on Packaging Operations

PCI Pharma Services

The deadlines for including unique product identifiers on prescription drugs is putting a strain on multiple parts of the industry, much of which is ill-prepared to meet the target. Here, we look to the experience of a company that is ahead of the curve for lessons on how to manage and ease the transition to serialisation.
More info >>

 
Industry Events

5th Biennial Biosimilars & Biobetters Congress 2018

16-17 April 2018, Novotel London West Hotel, Hammersmith, London

Oxford Global are proud to present our highly anticipated 5thBiennial Biosimilars & Biobetters Congress, 16th – 17thApril 2018, London, UK. Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions will enjoy over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement